Cargando…
DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer
The DAB2IP tumor suppressor encodes a RAS GTPase-activating protein. Accordingly, DAB2IP has been shown to be mutated or suppressed in tumor types that typically lack RAS mutations. However, here we report that DAB2IP is mutated or selectively silenced in the vast majority of KRAS and BRAF mutant co...
Autores principales: | Miller, Abigail L., Perurena, Naiara, Gardner, Alycia, Hinoue, Toshinori, Loi, Patrick, Laird, Peter W., Cichowski, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236151/ https://www.ncbi.nlm.nih.gov/pubmed/36939385 http://dx.doi.org/10.1158/0008-5472.CAN-22-0370 |
Ejemplares similares
-
The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer
por: Harrell Stewart, Desmond R., et al.
Publicado: (2020) -
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells
por: Duan, Yifan, et al.
Publicado: (2020) -
A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP
por: Bellazzo, Arianna, et al.
Publicado: (2018) -
Cigarette smoke affects the onco-suppressor DAB2IP expression in bronchial epithelial cells of COPD patients
por: Anzalone, Giulia, et al.
Publicado: (2019)